AT2220 Terminated Phase 2 Trials for Pompe's Disease Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00688597Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease